Anna G Figueroa

Title: Innovations by Anna G Figueroa in Age-Related Macular Degeneration Treatment

Introduction

Anna G Figueroa is an accomplished inventor based in Tucson, AZ. She has made significant contributions to the field of therapeutic compositions aimed at treating age-related macular degeneration (AMD). Her innovative work focuses on methods and systems that enhance the understanding and treatment of this prevalent eye condition.

Latest Patents

Anna G Figueroa holds a patent for "Methods and systems for screening therapeutic compositions for treating age-related macular degeneration." This invention involves culturing retinal pigment epithelium cells (RPE) and measuring the level of hypoxia-induced exosome release from these cells. The findings can be correlated with the onset and severity of AMD, providing a valuable tool for researchers and clinicians.

Career Highlights

Figueroa is affiliated with the University of Arizona, where she continues to advance her research in the field of ophthalmology. Her dedication to innovation has led to the development of effective screening methods that could potentially transform the treatment landscape for AMD.

Collaborations

Some of her notable coworkers include Brian S McKay and Nicole R Congrove, who contribute to her research efforts and help in the advancement of her innovative projects.

Conclusion

Anna G Figueroa's work exemplifies the intersection of innovation and healthcare, particularly in the treatment of age-related macular degeneration. Her contributions are paving the way for new therapeutic approaches that could significantly improve patient outcomes.